Actor Colin Egglesfield, whose credits include "All My Children" and "Something Borrowed," has announced he was diagnosed ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

VMMC and Safdarjung Hospital successfully performed their inaugural CAR-T cell therapy for cancer treatment, marking a ...

Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Emmy-winning 'Today' show weatherman Al Roker will be in Des Moines this weekend to serve as the keynote speaker for the 2025 ...

Furness Prostate Cancer Support Group urge men to come forward who have been refused a PSA test from their GP.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.

Colin Egglesfield is recovering from prostate cancer surgery after being diagnosed with the disease for the third time.

2025 is set to be a game-changing year for cancer research, with cutting-edge therapies and technologies driving unprecedented progress in oncology.